Cargando…

Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level

BACKGROUND: In an era of a growing economic pressure for all health systems, the interest for “disinvestment” in healthcare increased. In this context, evidence based approaches such as Health Technology Assessment (HTA) are needed both to invest and to disinvest in health technologies. In order to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calabrò, G. E., La Torre, G., de Waure, C., Villari, P., Federici, A., Ricciardi, W., Specchia, M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831213/ https://www.ncbi.nlm.nih.gov/pubmed/29490647 http://dx.doi.org/10.1186/s12913-018-2941-0

Ejemplares similares

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
por: Allen, Nicola, et al.
Publicado: (2017)

What influences the outcome of active disinvestment processes in healthcare? A qualitative interview study on five recent cases of active disinvestment
por: Rotteveel, Adriënne H., et al.
Publicado: (2021)

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
por: Makady, Amr, et al.
Publicado: (2017)

The development of HTA collaboration at European level and the challenge of the EU regulation
por: Ruether, A, et al.
Publicado: (2022)

The Utility of a Rapid Review Evaluation Process to a National HTA Agency
por: Varley, Áine, et al.
Publicado: (2021)

Are undocumented migrants’ entitlements and barriers to healthcare a public health challenge for the European Union?
por: De Vito, Elisabetta, et al.
Publicado: (2016)

The ASTUTE Health study protocol: Deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment
por: Watt, Amber M, et al.
Publicado: (2012)

FROM TALK TO ACTION: POLICY STAKEHOLDERS, APPROPRIATENESS, AND SELECTIVE DISINVESTMENT
por: Paprica, P. Alison, et al.
Publicado: (2015)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019)

Planning and Organization of the COVID-19 Vaccination Campaign: An Overview of Eight European Countries
por: Cadeddu, Chiara, et al.
Publicado: (2022)

Sustainability in Health care by Allocating Resources Effectively (SHARE) 9: conceptualising disinvestment in the local healthcare setting
por: Harris, Claire, et al.
Publicado: (2017)

Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations
por: Yuba, Tania Yuka, et al.
Publicado: (2018)

POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022)

An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy
por: La Torre, Giuseppe, et al.
Publicado: (2008)

HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization
por: van Dorst, P, et al.
Publicado: (2022)

Reorienting programme budgeting and marginal analysis (PBMA) towards disinvestment
por: Mortimer, Duncan
Publicado: (2010)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

Overview of the European Medicines Agency's Development of Product‐Specific Bioequivalence Guidelines
por: Sullivan, Jane O', et al.
Publicado: (2018)

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project
por: GASPARINI, R., et al.
Publicado: (2015)

HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites
por: Rojas, P, et al.
Publicado: (2022)

Disinvestment in the presence of uncertainty: Description of a novel, multi-group, disinvestment trial design and protocol for an application to reduce or cease use of mobilisation alarms for preventing falls in hospitals
por: Haines, Terry P., et al.
Publicado: (2021)

Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis
por: Wilson, Michael G, et al.
Publicado: (2014)

Benefits and challenges of Big Data in healthcare: an overview of the European initiatives
por: Pastorino, Roberta, et al.
Publicado: (2019)

A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies
por: Ibargoyen-Roteta, Nora, et al.
Publicado: (2022)

A perspective on the assessment of the broad value of vaccinations
por: de Waure, C, et al.
Publicado: (2022)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Understanding Health Professional Responses to Service Disinvestment: A Qualitative Study
por: Mitchell, Deb, et al.
Publicado: (2019)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices
por: Elshaug, Adam G, et al.
Publicado: (2007)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Sustainability in Health care by Allocating Resources Effectively (SHARE) 2: identifying opportunities for disinvestment in a local healthcare setting
por: Harris, Claire, et al.
Publicado: (2017)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
por: Lemos, Livia Lovato Pires de, et al.
Publicado: (2017)

The impact of disinvestment on alcohol and drug treatment delivery and outcomes: a systematic review
por: Roscoe, Suzie, et al.
Publicado: (2021)

Disinvestment in Higher Education and its Impact on Society: Case of Illinois Public Universities
por: Greenfield, Richard J., et al.
Publicado: (2022)

Not built for families: Associations between neighborhood disinvestment and reduced parental cognitive stimulation
por: Canfield, Caitlin F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9j3q6fkopgsn15tql8b2q0mi9